Streetlab

Their core work

Streetlab is a Paris-based SME specialized in real-world evaluation and validation of assistive technologies for people with visual impairments. They bridge the gap between laboratory research and everyday usability by conducting functional testing, patient-reported outcome assessments, and user-centered validation studies related to vision loss and eye diseases. Their work spans from event-driven computer vision systems for mobile accessibility to clinical endpoint validation for age-related macular degeneration and vision restoration therapies.

What they specialise in

How they've shifted over time

Streetlab's trajectory shows a clear shift from digital technology toward medical vision science. Their earliest project (ECOMODE, 2015) focused on event-driven computer vision and mobile device interaction — a purely technical, digital endeavor. From 2017 onward, their work pivoted decisively toward ophthalmology and vision health, with MACUSTAR addressing AMD clinical validation and ENTRAIN VISION focusing on vision restoration therapies. This evolution suggests a company that applied its initial vision technology expertise to the medically urgent domain of visual impairment.

Streetlab is moving deeper into clinical validation and therapeutic evaluation for eye diseases, positioning itself as a real-world testing partner for vision restoration research.

How they like to work

Streetlab operates exclusively as a contributing partner or third-party expert — they have never coordinated an H2020 project. With 33 unique partners across 12 countries from just 3 projects, they integrate into large, established consortia rather than leading them. This profile suggests an organization valued for its specialized testing and validation capabilities, brought in by larger research groups who need real-world user evaluation expertise.

Despite only three projects, Streetlab has built a broad network of 33 partners across 12 countries, reflecting their participation in large multi-national consortia in the ophthalmology and vision science space. Their network is decidedly pan-European with no narrow geographic concentration.

What sets them apart

Streetlab occupies a rare niche as a private company specializing in real-world usability and functional validation of vision-related technologies and therapies. While most partners in ophthalmology consortia are hospitals or universities, Streetlab brings an independent, user-centered evaluation perspective — testing how research outcomes translate to actual daily life for visually impaired people. For consortium builders, they offer a credible industry validation partner that satisfies both clinical rigor and real-world relevance requirements.

Highlights from their portfolio

• MACUSTAR
  Large-scale clinical validation study for intermediate AMD running until 2024, where Streetlab contributed as a third-party expert — indicating trusted specialist status in ophthalmology outcome measures.
• ENTRAIN VISION
  Marie Skłodowska-Curie training network on vision restoration therapies, showing Streetlab's role in training the next generation of vision scientists alongside academic partners.